Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

OMER:US

20.8700 USD 0.0600 0.29%

As of 20:10:00 ET on 02/27/2015.

Snapshot for Omeros Corp (OMER)

Open: 20.8100 Day's Range: 20.6800 - 21.1300 Volume: 901,416
Previous Close: 20.9300 52wk Range: 9.7606 - 25.8399 1-Yr Rtn: +56.21%

Stock Chart for OMER

No chart data available.
  • OMER:US 20.8700
  • 1D
  • 1M
  • 1Y
20.9300
Interactive OMER Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OMER

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.9392
Est. EPS (USD) (12/2014) -2.2570
Est. PEG Ratio -
Market Cap (M USD) 775.88
Shares Outstanding (M) 37.18
30 Day Average Volume 366,421
Price/Book (mrq) -
Price/Sale (ttm) 1,269.8252
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OMER

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OMER

Omeros Corporation is a biopharmaceutical company developing a pipeline of product candidates for use in orthopedics, rheumatology, urology, cardiovascular medicine, general surgery and pain management.

Gregory A DemopulosChairman/Pres/CEO/Co-FounderMichael A JacobsenVP:Finance/Chief Acctg Officer
George A GaitanarisVP:Science/Chief Scientific OfcrJ Steven WhitakerVP:Clinical/Chief Medical Ofcr
More Company Profile & Key Executives for OMER

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil